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ABSTRACT 27 
Background: In patients who survived out-of-hospital cardiac arrest (OHCA) it is crucial to establish 28 
the underlying cause and its potential reversibility. Objective: We assessed the incremental 29 
diagnostic and prognostic role of early cardiac magnetic resonance (CMR) in survivors of OHCA. 30 
Methods: Among 139 consecutive OHCA patients, we enrolled 44 (median age 43 years; 84% males) 31 
patients who underwent coronary angiography and CMR ≤7 days after admission. The CMR protocol 32 
included T2-weighted sequences for myocardial edema and late gadolinium-enhancement (LGE) 33 
sequences for myocardial fibrosis. Results: Coronary angiography identified obstructive coronary 34 
artery disease (CAD) in 18/44 patients, in whom CMR confirmed the diagnosis of ischemic heart 35 
disease by demonstrating subendocardial or transmural LGE; the presence of myocardial edema 36 
allowed to differentiate between acute myocardial ischemia (N=12) and post-infarction myocardial 37 
scar (N=6). Among the remaining 26 patients without obstructive CAD, 19 (73%) showed at CMR 38 
dilated cardiomyopathy (N=5), myocarditis (N=4), mitral valve prolapse associated with LGE (N=3), 39 
ischemic scar (N=2), idiopathic non-ischemic scar (N=2), arrhythmogenic cardiomyopathy (N=1), 40 
hypertrophic cardiomyopathy (N=1) and Tako-Tsubo cardiomyopathy (N=1). In this subgroup, 6/26 41 
(23%) had myocardial edema. During a mean follow-up of 36±17 months, all 18 patients with 42 
myocardial edema had an uneventful outcome while 9/26 (35%) without myocardial edema 43 
experienced sudden arrhythmic death (N=1), appropriate defibrillator interventions (N=5) and non-44 
arrhythmic death (N=3) (p=0.006). Conclusions: In survivors of OHCA, early CMR with a 45 
comprehensive tissue characterization protocol provided additional diagnostic and prognostic value. 46 
The identification of myocardial edema was associated with a favorable long-term outcome. 47 
Key Words: cardiac arrest; cardiopulmonary resuscitation; cardiac blunt trauma; cardiac magnetic 48 
resonance; implantable cardioverter defibrillator; secondary prevention; ventricular arrhythmia.  49 
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INTRODUCTION 50 
 Out-of-hospital cardiac arrest (OHCA) due to ventricular fibrillation (VF) or pulseless 51 
ventricular tachycardia (VT) can be caused by ischemic and non-ischemic heart diseases. In patients 52 
who suffered OHCA, clinical investigations aim at establishing what is the underlying disease and 53 
whether the cause of the arrhythmia is reversible. This is particularly relevant for decision to 54 
implant a defibrillator (ICD), that is not indicated in patients who experienced VT/VF due to a 55 
reversible myocardial injury like that secondary to myocardial ischemia of acute coronary 56 
syndromes or myocarditis[1-2]. In this contest, the interpretation of standard investigations such as 57 
ECG, echocardiography and coronary angiography may not be straightforward and nonspecific 58 
findings secondary to the cardiac arrest and subsequent resuscitation may act as confounders[3-5]. 59 
 Cardiac magnetic resonance (CMR), in addition to accurate assessment of ventricular 60 
function, allows the identification of myocardial tissue changes such as myocardial edema as 61 
evidenced by increased signal intensity on T2-weighted sequences and myocardial fibrosis by late 62 
gadolinium enhancement (LGE) on post-contrast sequences[6]. In the evaluation of patients who 63 
survived OHCA, the combination of sequences for myocardial edema and fibrosis has the potential 64 
to distinguish an acute and potentially reversible injury from a chronic and irreversible lesion[7].  65 
 The aim of the present study was to prospectively evaluate the incremental diagnostic and 66 
prognostic value of early (within one week after admission) CMR, enhanced with an accurate tissue 67 
characterization protocol including sequences for myocardial edema and fibrosis, in OHCA 68 
survivors.  69 
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METHODS 70 
 The study included all survivors of arrhythmic OHCA who were admitted to our institution 71 
during the study period 2011-2016 and underwent coronary angiography and CMR within one week 72 
of hospitalization. The CMR was performed in all patients who could be weaned from mechanical 73 
ventilation, had no neurological impairment and had no contraindications to CMR. The study 74 
complies with the Declaration of Helsinki, was approved by the Ethical Committee and all patients 75 
agreed to participate. 76 
Coronary angiography 77 
 Coronary angiography was performed in all patients: at admission in those with ST-segment 78 
elevation at post-resuscitation ECG or in those with high clinical suspicious of ongoing myocardial 79 
ischemia; delayed in the others. A culprit coronary lesion was defined as obstructive (≥70%) CAD 80 
with TIMI 0/1 flow with abrupt closure, or TIMI 2/3 flow with features suggestive of thrombus or 81 
ulcerated plaques, ST segment and T wave changes in the corresponding ECG location, and 82 
evidence of matching regional wall motion abnormality on left ventriculogram or 83 
echocardiogram[8]. 84 
Contrast-enhanced cardiac magnetic resonance 85 
 The CMR scan protocol systematically included steady-state free precession sequence (true 86 
FISP) cine images for morpho-functional evaluation, T2-weighted sequences for detection of 87 
myocardial edema and post-contrast sequences for detection of LGE. Details are reported in the 88 
supplemental file. 89 
Follow-up 90 
 Patients were followed-up with serial outpatient evaluations or with telephonic interviews to 91 
determine the alive status and whether they reached the composite arrhythmic end-point including 92 
sudden death, cardiac arrest due to VF, sustained VT and appropriate ICD intervention. Sudden                     93 
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death was defined as any natural death occurring instantaneously or within 60 minutes from 94 
symptoms onset. Appropriate ICD intervention was defined as an ICD shock delivered in response 95 
to a ventricular tachyarrhythmia >170 bpm and documented by stored intracardiac ECG data. All 96 
ICD interventions were adjudicated as appropriate or inappropriate by two electrophysiologists 97 
(AZ, DC) based on morphologic features, tachycardia onset, rate stability and atrial electrograms 98 
(when available). ICD were programmed according to the MADIT-RIT trial high-rate or delayed-99 
therapy programming[9].  100 
 101 
Statistical Analysis 102 
 Continuous and categorical variables are expressed as median (with 25th-75th %iles), and n 103 
(%), respectively. Because of the small sample size, normality distribution was not assumed. 104 
Categorical variables were compared by using the chi-square or Fisher exact test, as appropriate. 105 
Continuous data were compared using the Mann-Whitney U test. A p-value of <0.05 was 106 
considered statistically significant. Data were analysed with SPSS® version 23 (IBM®).   107 
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RESULTS 108 
 Among a consecutive series of 139 patients admitted for OHCA, 37 (27%) died during the 109 
acute phase. Among the remaining 102 patients, 58 (42%) were not recruited because of neurological 110 
impairment and/or mechanical ventilation (N=52), the presence of a no-MRI compatible pacemaker 111 
(N=4) or poor CMR quality images (N=2). Forty-four patients [median age 43 years (39-62 years); 112 
84% males] met the enrollment criteria and constituted the definitive study cohort. (Table 1). 113 
Coronary angiography was performed at admission in 20 (45%) patients, including 7 (16%) with 114 
post-resuscitation ST-segment elevation, and within 4 days in the remaining patients. 115 
 116 
Obstructive CAD 117 
 Angiographic evidence of obstructive coronary disease (≥1 coronary stenosis ≥70%) was 118 
found in 18 (41%) patients. A clear culprit coronary lesion was identified in 10 patients, 5/5 with 119 
single vessel disease and 5/13 with multiple vessels disease.  120 
Cardiac magnetic resonance findings are summarized in Table 2.  121 
The presence of myocardial edema at T2-weighted sequences consistent with an acute 122 
ischemic injury in 12/18 (67%) patients (Figure 1). In all cases, the regional distribution of myocardial 123 
edema was concordant with the territory which was tributary of a coronary artery with obstructive 124 
stenosis or occlusion. In 10 patients with an identifiable culprit coronary lesion, the regions of 125 
myocardial edema were always concordant with the regional distribution of the culprit coronary 126 
artery. Myocardial edema was present in 2 of the 8 patients with multiple vessels disease and no 127 
identifiable culprit coronary lesion. The Peak troponin I (normal value <0.017 ug/L) was significantly 128 
higher in patients with [12.2 ug/L (2.1-104.8)] compared with those without [2.8 ug/L (1.2-26.1)] LV 129 
myocardial edema (p = 0.02). 130 
 Left ventricular LGE with a subendocardial or transmural distribution was demonstrated in 131 
all patients (Figure 2). Among the 12 patients with myocardial edema, the regional distribution of LV 132 
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LGE corresponded to the edematous LV segments in 8 (consistent with an acute myocardial ischemic 133 
injury without previous myocardial infarction) and extended to other non-edematous segments in 4 134 
(consistent with an acute myocardial ischemic injury superimposed on a previous post-myocardial 135 
infarction scar).  136 
 Right ventricular LGE was present in a patient with right ventricular myocardial infarction 137 
due to occlusion of the proximal right coronary artery. 138 
 139 
No obstructive CAD 140 
 Among the 26 (59%) patients with non-obstructive CAD, coronary angiography revealed 141 
normal coronary arteries in 20 and non-obstructive coronary artery stenosis in 6. A negative history 142 
of cardiac disease at risk of sudden cardiac death was documented in all but one patient with a 143 
previous diagnosis of HCM. CMR allowed to identify a pathological myocardial substrate in 19 144 
(73%) consistent with dilated cardiomyopathy (N=5); acute myocarditis (N=4, Figure 3), mitral valve 145 
prolapse associated with LGE (N=3, Figure 4); ischemic heart disease (N=2), isolated non-ischemic 146 
left ventricular scar (N=2, Figure 5), arrhythmogenic cardiomyopathy (N=1), hypertrophic 147 
cardiomyopathy (N=1) and Tako-Tsubo cardiomyopathy (N=1) (Table 2). 148 
 Left ventricular myocardial edema was present in 6 (23%) patients. The following regional 149 
distribution patterns of myocardial edema were identified: 1) midmyocardial or subepicardial pattern 150 
involving the infero-lateral LV wall in 4 patients, consistent with a diagnosis of acute myocarditis 151 
which was confirmed by endomyocardial biopsy in 3; 2) a subendocardial pattern in the mid-apical 152 
antero-septal LV segments consistent with myocardial ischemia in one patient with a left anterior 153 
descending artery stenosis that was judged as moderate at coronary angiography; 3) a transmural 154 
pattern affecting circumferentially the mid-apical LV segments in one patient who received a 155 
diagnosis of Tako-tsubo cardiomyopathy. 156 
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 Left ventricular LGE was present in 18 (69%) patients, including 2 with ischemic distribution 157 
(subendocardial or transmural) and 16 with a non-ischemic pattern (midmyocardial or subepicardial). 158 
Non-ischemic myocardial fibrosis was found in isolation in 2 patients, and associated with other 159 
cardiac diseases in the remaining 15 cases (i.e., cardiomyopathies, N=7; acute myocarditis, N=4; and 160 
mitral valve prolapse, N=3).  161 
 Right ventricular LGE was present in two patients who fulfilled the International Task Force 162 
diagnostic criteria for arrhythmogenic cardiomyopathy[10]. 163 
  164 
Incremental diagnostic value of CMR  165 
 In all 18 patients with obstructive CAD, tissue characterization by CMR confirmed the clinical 166 
diagnosis of arrhythmic OHCA due to either acute coronary syndrome (N=12) or chronic ischemic 167 
cardiac disease (post-infarction left ventricular scar with no evidence of acute myocardial edema) 168 
(N=6). 169 
 Among the 26 OHCA survivors with no obstructive CAD, CMR modified the initial clinical 170 
diagnosis in 11 (42%). Details are reported in Table 3 and Supplemental file.  171 
 172 
Clinical management  173 
An ICD was implanted in all patients with no evidence of acute ischemic injury (no LV 174 
myocardial edema), but one who underwent surgical coronary revascularization and had a negative 175 
electrophysiological study with programmed ventricular stimulation performed 12 days after surgery. 176 
In addition, 5/12 OHCA survivors with evidence of acute myocardial infarction also received an ICD 177 
because of severe reduction of LV ejection fraction after 40 days despite optimal medical therapy 178 
(N=4) or moderate LV dysfunction in association with non-sustained VT and inducibility of sustained 179 
VT at programmed ventricular stimulation (N=1). 180 
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Among the 26 OHCA survivors with no obstructive CAD, an ICD was implanted in 22. The 181 
remaining 4 OCHA survivors did not receive an ICD for the following reasons: one with mitral valve 182 
prolapse and severe mitral regurgitation underwent mitral valve repair and had a negative 183 
electrophysiological study with programmed ventricular stimulation 15 days after surgery; one 184 
patient with arrhythmogenic cardiomyopathy refused the device implantation; and in 2 patients with 185 
acute myocarditis the ICD was deemed not indicated. 186 
 187 
Follow-up 188 
Overall, the mean follow-up period was 36±17 months and no patients were lost to follow-up. 189 
Five patients experienced appropriate ICD interventions and one patient, who refused ICD 190 
implantation, died suddenly. The 6 patients with arrhythmic events during follow-up showed no 191 
myocardial edema at CMR while all 18 patients who received a diagnosis of reversible myocardial 192 
damage based on CMR evidence of acute myocardial ischemia (N=13), acute myocarditis (N=4) or 193 
Tako-Tsubo cardiomyopathy (N=1), had an uneventful arrhythmic outcome. Five patients with 194 
obstructive CAD had severe LV dysfunction at CE-CMR: of those, 3 died for non-arrhythmic causes 195 
(refractory heart failure, acute myocardial infarction and abdominal aorta aneurysm rupture) and 1 196 
experienced appropriate ICD intervention. The other 5 patients with arrhythmic events during follow-197 
up had a normal or mildly reduced LV function.  198 
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DISCUSSION 199 
In survivors of OHCA the identification of the underlying arrhythmic myocardial substrate 200 
has important implications for patients’ management. Arrhythmic cardiac arrest may be the result of 201 
different mechanisms and substrates which include: i) acute and transient electrical instability such 202 
that occurring in the setting of acute myocardial ischemia or myocarditis, ii) rapid VT related to a 203 
chronic myocardial scar resulting from a previous myocardial infarction or in the context of a 204 
cardiomyopathy and iii) primarily electrical disease including genetically-determined ion channel 205 
disease, drug toxicity or electrolyte imbalance in the absence of structural heart diseases. With regard 206 
to the pathophysiological meaning of myocardial edema, it may either represent the bystander 207 
hallmark of an acute cardiac injury (e.g. in acute myocardial infarction) or directly cause ventricular 208 
arrhythmias by causing depolarization/repolarization inhomogeneity of myocardium [11]. 209 
According to current guidelines[1-2], ICD therapy for secondary prevention of sudden death 210 
is reserved to patients with a stable myocardial substrate which exposes to persistent risk of VT/VF 211 
relapses. On the contrary, ICD implantation is not justified in patients who suffered VT/VF due to 212 
reversible causes, Interpretation of standard investigations such as ECG, echocardiography and 213 
coronary angiography may not be straightforward to detect the cause of OHCA and structural 214 
substrates of life-threatening ventricular arrhythmias may remain concealed[12-13]; in addition, 215 
features of the so-called “post-resuscitation syndrome” may further confuse the clinical diagnosis[3-216 
5].  217 
This study was designed to evaluate the diagnostic yield and prognostic implication of early 218 
CMR study with a comprehensive protocol for tissue characterization, including T2-weighted 219 
sequences for myocardial edema and post-gadolinium sequences for myocardial fibrosis in a cohort 220 
of OHCA survivors with and without obstructive coronary artery disease at coronary angiography 221 
who underwent CE-CMR within one week after the event. The main findings were the following: 1) 222 
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acute CMR study provided additional value for the identification of causes and mechanisms 223 
responsible for arrhythmic OHCA; 2) the evaluation of the presence and regional distribution of both 224 
myocardial edema and fibrosis allowed to differentiate acute and reversible myocardial lesions from 225 
chronic and stable myocardial substrates, with significant implications on ICD therapy decision-226 
making; 3) identification of acute myocardial edema by CMR predicted an uneventful arrhythmic 227 
outcome during follow-up; 4) in our population of OHCA survivors, we did not find any tissue 228 
abnormalities at CMR suggestive of post-resuscitation myocardial contusion. 229 
Previous studies 230 
Previous studies showed that CMR provides incremental diagnostic value in patients who 231 
survived an OHCA [14-17], but CMR scan protocols were often not uniform and performed late after 232 
the acute event, thus reducing the sensitivity of T2-weighted sequences for myocardial edema. 233 
Moreover, follow-up data to assess the prognostic value of comprehensive CMR tissue 234 
characterization in OHCA are lacking. More details are reported in the supplemental file. 235 
Our results confirm and extend previous observations on the diagnostic and prognostic value 236 
of CMR in the setting of OHCA. In our study, the tissue characterization imaging protocol 237 
incorporated systematic evaluation of both myocardial edema and LGE in order to distinguish acute 238 
and potentially reversible myocardial injury from chronic and irreversible tissue damage[6-7]. At 239 
variance with previous studies, all our patients underwent early CMR, i.e. within 7 days of 240 
hospitalization, in order to provide the highest sensitivity for detection of transient myocardial edema 241 
and were followed-up for a mean of 3 years to prospectively assess the prognostic value of CMR 242 
findings. 243 
Diagnostic yield 244 
In patients with obstructive CAD, CMR confirmed the diagnosis of ischemic heart disease by 245 
showing LGE with an ischemic distribution (subendocardial or transmural) in all cases. In addition, 246 
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T2-weighted sequences allowed to differentiate the arrhythmic substrate due to acute myocardial 247 
ischemia, as suggested by the presence of myocardial edema in the territory tributary of a coronary 248 
artery, from that of post-infarction myocardial scar[18]. The tissue characterization was also useful 249 
for identification or confirmation of the culprit coronary artery, particularly in patients with multiple 250 
vessels disease and equivocal coronary angiography findings.  251 
In patients without obstructive CAD, CMR confirmed the clinical diagnosis in 58% of cases 252 
and modified the clinical diagnosis in 42% by demonstrating previously unrecognized myocardial 253 
substrates. Myocardial edema at T2-weighted sequences was present in 6 cases suggesting that the 254 
OHCA was the result of an acute myocardial injury occurring in the setting of acute coronary 255 
syndrome, myocarditis or Tako-tsubo cardiomyopathy. In the remaining patients without myocardial 256 
edema, ventricular fibrillation was related to cardiomyopathies or recently identified substrates of 257 
SCD such as the isolated non-ischemic myocardial scar [13] or the “arrhythmic” mitral valve prolapse 258 
(i.e. floppy mitral valve associated with myocardial fibrosis that is localized at the base of the 259 
papillary muscle or at the basal posterior wall behind the mitral leaflet) [19]. 260 
Prognostic implications 261 
Although definite conclusions cannot be drawn because of the limited sample size, our study 262 
results suggest that CMR may provide not only diagnostic but also prognostic information. Compared 263 
with tissue characterization based on LGE alone, demonstration of myocardial edema by T2-weighted 264 
CMR sequences was of additional value for establishing the acute and potentially reversible nature 265 
of the arrhythmic myocardial substrate. These results have the potential to impact ICD decision 266 
making because indications to device implantation depends on demonstration of chronic/non-267 
reversible myocardial lesion as the substrate underlying VT/VF[1-2]. In our study, patients with 268 
myocardial edema suggesting an acute and potentially reversible myocardial lesion showed no 269 
arrhythmic events over a mean follow-up of 3 years. By comparison, 23% of patients without 270 
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myocardial edema at CMR, who most likely had a chronic and non-reversible substrate, suffered 271 
arrhythmic events during follow-up. 272 
Myocardial damage secondary to resuscitation 273 
 The diagnostic accuracy of CMR has been definitely demonstrated in non-OHCA patients 274 
and it is now applied in a variety of cardiac conditions. However, clinical interpretation of tissue 275 
abnormalities in survivors of OHCA poses additional challenges because all patients received 276 
cardiopulmonary resuscitation that may cause cardiac contusion. In our study we found no signs 277 
suggestive of post-resuscitation myocardial contusions. Accordingly, myocardial edema at T2-278 
weighted sequences in patients with OHCA should be interpreted as the sign of an underlying 279 
disease rather than a non-specific post-resuscitation injury. More details are reported in the 280 
Supplemental File. 281 
Study limitations 282 
The main limitations of the study are that it was retrospective and conducted at a single 283 
center. Moreover, our study reported on a relatively small number of patients and outcomes because 284 
survivors of OHCA were rare and only a minority of them (32%) were eligible for early CMR. 285 
Accordingly, our findings should be confirmed by further studies on larger populations and longer 286 
follow-up before the use of early CMR for ICD-decision making in survivors of OHCA can be 287 
clinically implemented. 288 
In our study, the majority of patients were diagnosed with non-ischemic heart disease in 289 
contrast with previous studies demonstrating that obstructive coronary artery disease is the most 290 
common cause of OHCA [3]. This finding reflects the selection of patients because only OHCA 291 
survivors who were able to undergo early CMR were included in the study. Therefore, the 292 
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distribution of OHCA substrates of our study sample cannot be considered representative of the 293 
general population.  294 
Conclusions 295 
In survivors of OHCA, tissue characterization by early CMR was of significant diagnostic 296 
and prognostic value in addition to standard clinical investigation (Supplemental figures 1 and 2). 297 
Demonstration of myocardial edema by T2-weighted sequences, suggesting an acute and potentially 298 
reversible myocardial injury, was associated with an uneventful arrhythmic follow-up. These 299 
findings suggest that early CMR with T2-weighted sequences may be helpful to guide the decision 300 
to implant an ICD for secondary prevention in survivors of OHCA that, according to current 301 
guidelines, depends on the exclusion of possible transient and reversible causes for VT/VF such as 302 
acute myocardial ischemia or acute myocarditis. 303 
 304 
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FIGURES LEGEND 369 
 370 
Figure 1. Out-of-hospital cardiac arrest in a patient with obstructive coronary artery disease. 371 
Out-of-hospital cardiac arrest occurring in a 64-year-old male with acute coronary syndrome. 372 
Coronary angiography showing multiple vessels obstructive (≥70%) coronary artery stenosis (arrows) 373 
affecting both the right (A) and the left (B) coronary artery. Cardiac magnetic resonance showing 374 
transmural myocardial edema (three chambers, long axis view; T2-weighted sequences) (C) and 375 
subendocardial late gadolinium enhancement (three chamber, long axis view; T1-weighted inversion 376 
recovery post-contrast sequences) (D) affecting the infero-lateral left ventricular wall which is 377 
tributary of the left circumflex coronary artery. 378 
 379 
Figure 2. Out-of-hospital cardiac arrest in a patient with obstructive coronary artery disease. 380 
Out-of-hospital cardiac arrest occurring in a 57-year-old male with post-myocardial infarction scar. 381 
Coronary angiography showing multiple vessels obstructive (≥70%) coronary artery stenosis 382 
(arrows) affecting both the right (A) and the left (B) coronary artery. Cardiac magnetic resonance 383 
showing no myocardial edema (three chambers, long axis view; T2-weighted sequences) (C) and 384 
transmural late gadolinium enhancement (three chambers, long axis view; T1-weighted inversion 385 
recovery post-contrast sequences) (D) affecting the entire left ventricular lateral wall which is 386 
tributary of the left circumflex coronary artery. 387 
 388 
 389 
Figure 3. Out-of-hospital cardiac arrest in a patient with no obstructive coronary artery 390 
disease. 391 
Out-of-hospital cardiac arrest occurring in a 41-year-old male with biopsy-proven acute 392 
myocarditis. Coronary angiography showing normal right (A) and left (B) coronary artery. Cardiac 393 
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magnetic resonance showing myocardial edema (two chambers, long axis view; T2-weighted 394 
sequences) (C) and transmural late gadolinium enhancement (two chambers, long axis view; T1-395 
weighted inversion recovery post-contrast sequences) (D) affecting the mid-apical inferior left 396 
ventricular wall. 397 
 398 
Figure 4. Out-of-hospital cardiac arrest in a patient with no obstructive coronary artery 399 
disease. 400 
Out-of-hospital cardiac arrest occurring in a 29-year-old female with arrhythmic mitral valve 401 
prolapse. Coronary angiography showing normal right (A) and left (B) coronary artery. Cardiac 402 
magnetic resonance showing thickening and prolapse of both mitral valve leaflets (C,D), no 403 
myocardial edema (three chambers, long axis view; T2-weighted sequences) (C) and evidence of 404 
mid-myocardial late gadolinium enhancement (three chambers, long axis view; T1-weighted 405 
inversion recovery post-contrast sequences) (D) affecting the basal infero-lateral left ventricular 406 
wall behind the prolapsing posterior mitral valve leaflet. 407 
 408 
Figure 5. Out-of-hospital cardiac arrest in a patient with no obstructive coronary artery 409 
disease. 410 
Out-of-hospital cardiac arrest occurring in a 36-year-old male with an isolated non-ischemic left 411 
ventricular scar. Coronary angiography showing normal right (A) and left (B) coronary artery. 412 
Cardiac magnetic resonance showing no myocardial edema (four chambers, long axis view; T2-413 
weighted sequences) (C) and the presence of subepicardial late gadolinium enhancement (four 414 
chambers, long axis view; T1-weighted inversion recovery post-contrast sequences) (D) affecting 415 
almost the entire left ventricular lateral wall. 416 
 417 
  418 
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TABLES 419 
Table 1: clinical characteristics of the study population 420 
 Coronary 
stenosis  
≥ 70% 
N=18 
NO Coronary 
stenosis  
≥ 70% 
N=26 
P 
Gender (male) 17 (94%) 19 (73%) 0.11 
Age (years) 57 (54-71) 44 (27-59) <0.001 
Risk factors 
Hypertension 
Diabetes 
Smoking 
Dyslipidemia 
Family history for CAD 
 
13 (72%) 
6 (33%) 
8 (45%) 
8 (44%) 
4 (22%) 
 
5 (19%) 
2 (8%) 
4 (15%) 
5 (19%) 
4 (15%) 
 
0.001 
0.05 
0.04 
0.09 
0.70 
Personal history 
Ischemic heart disease 
Non-ischemic heart disease 
Chest pain within 1 month 
Syncope/pre-syncope 
 
4 (22%) 
0 
6 (33%) 
0 
 
0 
3 (12%) 
1 (4%)  
3 (12%) 
 
0.03 
0.25 
0.02 
0.25 
Characteristics of cardiac arrest 
Cardiac arrest in public place 
Witnessed cardiac arrest 
Bystander CPR 
ST-segment elevation post 
resuscitation 
 
11 (61%) 
17 (95%) 
11 (61%) 
7 (39%) 
 
9 (35%) 
23 (88%) 
22 (85%) 
0 
 
0.06 
0.63 
0.09 
<0.001 
Echocardiography at admission 
 LV EF (%) 
 LV EDVi (ml/m2) 
 LV regional WMA 
 RV dilation 
 RV dysfunction 
 RV regional WMA 
 Mitral valve regurgitation ≥ 
moderate  
 Mitral valve prolapse 
 Aortic valve stenosis ≥ moderate 
 
42 (33-50) 
71 (56-96) 
17 (94%) 
2 (11%) 
2 (11%) 
1 (6%) 
2 (11%) 
 
0 
0 
 
50 (47-56) 
69 (60-84) 
8 (31%) 
5 (19%) 
2 (8%) 
3 (12%) 
3 (12%) 
 
5 (19%) 
0 
 
0.014 
0.40 
<0.001 
0.68 
0.68 
1.0 
1.0 
 
0.06 
- 
Troponin I peak (umol/L) 5.1 (1.5-82) 1.2 (0.29-9.9) 0.02 
Coronary angiography 
At admission 
Time from admission 
Single vessel disease  
Multiple vessel disease with 
culprit lesion 
 
12 (67%) 
1 (0-3) 
5 (28%) 
5 (28%) 
 
 
8 (31%) 
2 (1-3) 
0 
0 
 
 
0.41 
0.55 
 
Clinical diagnosis (no CMR) 
Structurally normal heart* 
Ischemic heart disease 
Acute myocarditis 
Cardiomyopathy# 
Mitral valve prolapse 
 
0 
18 (100%) 
0 
0 
0 
 
12 (46%) 
1 (4%) 
3 (12%) 
5 (19%) 
5 (19%) 
 
<0.001 
* including Brugada syndrome, idiopathic catecholaminergic ventricular tachycardia, long QT syndrome, and short QT 421 
syndrome # including non-ischemic dilated cardiomyopathy, arrhythmogenic cardiomyopathy and hypertrophic 422 
cardiomyopathy 423 
 424 
CMR=cardiac magnetic resonance; ICD=implantable cardioverter defibrillator; LV=left ventricular; RV=right 425 
ventricular; TAPSE=tricuspid annular plane systolic excursion; WMA= wall motion abnormalities; TTS=Tako-tsubo 426 
syndrome427 
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Table 2: cardiac magnetic resonance findings in the study population 428 
 Coronary 
stenosis  
≥ 70% 
N=18 
NO Coronary 
stenosis  
≥ 70% 
N=26 
P 
Morpho-functional parameters 
 LV systolic function 
Normal 
Mild impairment 
Moderate impairment 
Severe impairment 
LVEDV 
 Normal 
 Mild dilation 
 Moderate dilation 
 Severe dilation 
 LV regional WMA 
 RV systolic impairment 
 RV dilatation  
 RV regional WMA  
 
 
3 (17%) 
3 (17%) 
7 (39%) 
5 (28%) 
 
7 (39%) 
6 (33%) 
2 (11%) 
3 (17%) 
17 (94%) 
1 (6%) 
0 
2 (11%) 
 
 
18 (69%) 
6 (24%) 
2 (8%) 
0 
 
20 (77%) 
3 (12%) 
2 (8%) 
1 (4%) 
5 (19%) 
4 (15%) 
1 (4%) 
3 (12%) 
 
 
<0.001 
 
 
 
 
0.03 
 
 
 
<0.001 
0.52 
1.0 
1.0 
LV Myocardial edema 
 Absent 
 Patchy, midmyocardial or 
subepicardial 
 Subendocardial 
 Transmural 
 
6 (33%) 
0 
 
1 (6%) 
11 (61%) 
 
20 (77%) 
4 (15%) 
 
1 (4%) 
1 (4%) 
 
0.002 
LV LGE  
 Absent 
 Midmyocardial or subepicardial 
 Subendocardial 
 Transmural 
 
0 
0 
7 (39%) 
11 (61%) 
 
7 (27%) 
17 (65%) 
1 (4%)  
1 (4%) 
 
<0.001 
RV LGE 1 (6%) 2 (8%) 1.0 
CMR diagnosis 
Structurally normal heart* 
Ischemic heart disease 
Acute myocarditis 
Cardiomyopathy# 
Mitral valve prolapse with LGE 
Tako-Tsubo syndrome 
Non-ischemic LV scar 
 
0 
18 (100%) 
0 
0 
0 
0 
0 
 
7 (27%) 
2 (8%) 
4 (15%) 
7 (27%) 
3 (12%) 
1 (4%) 
2 (8%) 
 
<0.001 
 429 
CMR=cardiac magnetic resonance; LGE=late-gadolinium enhancement; LVEDV= left ventricular end-diastolic 430 
volume; LV=left ventricular; RV=right ventricular; WMA= wall motion abnormalities;  431 
 432 
# including non-ischemic dilated cardiomyopathy, arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy  433 
434 
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Table 3 – comparison between clinical and cardiac magnetic resonance diagnosis  435 
Suspected diagnosis (pre-CMR) Final diagnosis (after-CMR) Agreement 
Structurally normal heart (N=12) Structurally normal heart = 7 
Acute myocarditis = 2 
Cardiomyopathy = 1 
Non-ischemic LV scar = 2 
7/12 (58%) 
Ischemic heart disease (N=19) Ischemic heart disease = 18 
Tako-tsubo syndrome = 1 
18/19 (95%) 
Acute myocarditis (N=3) Acute myocarditis = 1  
Ischemic heart disease = 1 
Cardiomyopathy = 1 
1/3 (33%) 
Cardiomyopathy (N=5) Cardiomyopathy = 4 
Ischemic heart disease = 1 
4/5 (80%) 
Mitral valve prolapse (N=5) Mitral valve prolapse with LGE = 3 
Cardiomyopathy = 1 
Acute myocarditis = 1 
3/5 (60%) 
 
Agreement Coronary stenosis ≥70% group 
NO coronary stenosis ≥70% group 
Overall agreement 
18/18 (100%) 
15/26 (58%) 
33/44 (75%) 
CMR=cardiac magnetic resonance; LGE=late gadolinium enhancement; LV=left ventricular 436 
